SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jason M Schifano, Nancy A Woychik, 23S rRNA as an a-Maz-ing new bacterial toxin target, RNA Biology, 2014, 11, 2

    CrossRef

  2. 2
    Xiaoling Wu, Guangcun Deng, Xiujing Hao, Yong Li, Jin Zeng, Chunyan Ma, Yulong He, Xiaoming Liu, Yujiong Wang, A Caspase-Dependent Pathway Is Involved in Wnt/β-Catenin Signaling Promoted Apoptosis in Bacillus Calmette-Guerin Infected RAW264.7 Macrophages, International Journal of Molecular Sciences, 2014, 15, 3, 5045

    CrossRef

  3. 3
    Jason M. Schifano, Irina O. Vvedenskaya, Jared G. Knoblauch, Ming Ouyang, Bryce E. Nickels, Nancy A Woychik, An RNA-seq method for defining endoribonuclease cleavage specificity identifies dual rRNA substrates for toxin MazF-mt3, Nature Communications, 2014, 5,

    CrossRef

  4. 4
    Qin Pan, Qilong Wang, Xiaoming Sun, Xianru Xia, Shimin Wu, Fengling Luo, Xiao-Lian Zhang, Aptamer Against Mannose-capped Lipoarabinomannan Inhibits Virulent Mycobacterium tuberculosis Infection in Mice and Rhesus Monkeys, Molecular Therapy, 2014, 22, 5, 940

    CrossRef

  5. 5
    Milena Lima de Moraes, Daniela Maria de Paula Ramalho, Karina Neves Delogo, Pryscila Fernandes Campino Miranda, Eliene Denites Duarte Mesquita, Hedi Marinho de Melo Guedes de Oliveira, Antônio Ruffino Netto, Marcelino José dos Anjos, Afrânio Lineu Kritski, Martha Maria de Oliveira, Association of Serum Levels of Iron, Copper, and Zinc, and Inflammatory Markers with Bacteriological Sputum Conversion During Tuberculosis Treatment, Biological Trace Element Research, 2014, 160, 2, 176

    CrossRef

  6. 6
    Ashley L. Garner, Leslie A. Weiss, Ana Ruiz Manzano, Eric A. Galburt, Christina L. Stallings, CarD integrates three functional modules to promote efficient transcription, antibiotic tolerance, and pathogenesis in mycobacteria, Molecular Microbiology, 2014, 93, 4
  7. You have free access to this content7
    G. Delogu, R. Manganelli, M. J. Brennan, Critical research concepts in tuberculosis vaccine development, Clinical Microbiology and Infection, 2014, 20,
  8. 8
    Geraldine Nouailles, Anca Dorhoi, Markus Koch, Jens Zerrahn, January Weiner, Kellen C. Faé, Frida Arrey, Stefanie Kuhlmann, Silke Bandermann, Delia Loewe, Hans-Joachim Mollenkopf, Alexis Vogelzang, Catherine Meyer-Schwesinger, Hans-Willi Mittrücker, Gayle McEwen, Stefan H.E. Kaufmann, CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis, Journal of Clinical Investigation, 2014, 124, 3, 1268

    CrossRef

  9. 9
    Govind Chandra, Keith F. Chater, Developmental biology of Streptomyces from the perspective of 100 actinobacterial genome sequences, FEMS Microbiology Reviews, 2014, 38, 3
  10. 10
    A. Cecilia Helguera-Repetto, Rommel Chacon-Salinas, Jorge F. Cerna-Cortes, Sandra Rivera-Gutierrez, Vianney Ortiz-Navarrete, Iris Estrada-Garcia, Jorge A. Gonzalez-y-Merchand, Differential Macrophage Response to Slow- and Fast-Growing Pathogenic Mycobacteria, BioMed Research International, 2014, 2014, 1

    CrossRef

  11. 11
    Ming Zhang, Jeffrey M. Chen, Claudia Sala, Jan Rybniker, Neeraj Dhar, Stewart T. Cole, EspI regulates the ESX-1 secretion system in response to ATP levels in Mycobacterium tuberculosis, Molecular Microbiology, 2014, 93, 4
  12. 12
    Young Jin Kim, Sun Min Lee, Byung Kyu Park, Sung Soo Kim, Jongyoun Yi, Hyung Hoi Kim, Eun Yup Lee, Chulhun Ludgerus Chang, Evaluation of Propidium Monoazide Real-Time PCR for Early Detection of ViableMycobacterium tuberculosisin Clinical Respiratory Specimens, Annals of Laboratory Medicine, 2014, 34, 3, 203

    CrossRef

  13. 13
    S.H.E. Kaufmann, Impfung gegen Tuberkulose, Der Pneumologe, 2014, 11, 1, 42

    CrossRef

  14. 14
    A. Zumla, M. Rao, S. K. Parida, S. Keshavjee, G. Cassell, R. Wallis, R. Axelsson-Robertsson, M. Doherty, J. Andersson, M. Maeurer, Inflammation and tuberculosis: host-directed therapies, Journal of Internal Medicine, 2014, 276, 3
  15. 15
    Marina Pinheiro, Ana Sofia Silva, Sílvia Pisco, Salette Reis, Interactions of isoniazid with membrane models: Implications for drug mechanism of action, Chemistry and Physics of Lipids, 2014, 183, 184

    CrossRef

  16. 16
    Tatiana Kondratieva, Tatyana Azhikina, Boris Nikonenko, Arseny Kaprelyants, Alexander Apt, Latent tuberculosis infection: What we know about its genetic control?, Tuberculosis, 2014,

    CrossRef

  17. 17
    Tae Sung Kim, Yi Sak Kim, Heekyung Yoo, Young Kil Park, Eun-Kyeong Jo, Mycobacterium massiliense Induces Inflammatory Responses in Macrophages Through Toll-Like Receptor 2 and c-Jun N-Terminal Kinase, Journal of Clinical Immunology, 2014, 34, 2, 212

    CrossRef

  18. 18
    Stefan H E Kaufmann, Christoph Lange, Martin Rao, Kithiganahalli N Balaji, Michael Lotze, Marco Schito, Alimuddin I Zumla, Markus Maeurer, Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review, The Lancet Respiratory Medicine, 2014, 2, 4, 301

    CrossRef

  19. 19
    Paweł Masiewicz, Marcin Wolański, Anna Brzostek, Jarosław Dziadek, Jolanta Zakrzewska-Czerwińska, Propionate represses the dnaA gene via the methylcitrate pathway-regulating transcription factor, PrpR, in Mycobacterium tuberculosis, Antonie van Leeuwenhoek, 2014, 105, 5, 951

    CrossRef

  20. 20
    Pooja Gopal, Thomas Dick, Reactive dirty fragments: implications for tuberculosis drug discovery, Current Opinion in Microbiology, 2014, 21, 7

    CrossRef

  21. 21
    Dunquan Jiang, Qingqing Zhang, Qianqian Zheng, Hao Zhou, Jin Jin, Weihong Zhou, Mark Bartlam, Zihe Rao, Structural analysis of Mycobacterium tuberculosis ATP-binding cassette transporter subunit UgpB reveals specificity for glycerophosphocholine, FEBS Journal, 2014, 281, 1
  22. 22
    Stefan HE Kaufmann, Mark F Cotton, Bernd Eisele, Martin Gengenbacher, Leander Grode, Anneke C Hesseling, Gerhard Walzl, The BCG replacement vaccine VPM1002: from drawing board to clinical trial, Expert Review of Vaccines, 2014, 13, 5, 619

    CrossRef

  23. 23
    Laam Li, Nilmini Mendis, Hana Trigui, James D. Oliver, Sebastien P. Faucher, The importance of the viable but non-culturable state in human bacterial pathogens, Frontiers in Microbiology, 2014, 5,

    CrossRef

  24. 24
    Jeffrey Green, Matthew D Rolfe, Laura J Smith, Transcriptional regulation of bacterial virulence gene expression by molecular oxygen and nitric oxide, Virulence, 2014, 5, 4

    CrossRef

  25. 25
    Benoit Lechartier, Jan Rybniker, Alimuddin Zumla, Stewart T Cole, Tuberculosis drug discovery in the post-post-genomic era, EMBO Molecular Medicine, 2014, 6, 2
  26. 26
    Stefan H.E. Kaufmann, Tuberculosis vaccine development at a divide, Current Opinion in Pulmonary Medicine, 2014, 20, 3, 294

    CrossRef

  27. 27
    Peter Andersen, Joshua S. Woodworth, Tuberculosis vaccines – rethinking the current paradigm, Trends in Immunology, 2014, 35, 8, 387

    CrossRef

  28. 28
    Anca Dorhoi, Stefan H.E. Kaufmann, Tumor necrosis factor alpha in mycobacterial infection, Seminars in Immunology, 2014, 26, 3, 203

    CrossRef

  29. 29
    Delia Goletti, Elisa Petruccioli, Alessandra Romagnoli, Mauro Piacentini, Gian Maria Fimia, Autophagy in Mycobacterium tuberculosis infection: A passepartout to flush the intruder out?, Cytokine & Growth Factor Reviews, 2013, 24, 4, 335

    CrossRef

  30. 30
    Leanne M. Smith, Robin C. May, Mechanisms of microbial escape from phagocyte killing, Biochemical Society Transactions, 2013, 41, 2, 475

    CrossRef

  31. 31
    J. M. Schifano, R. Edifor, J. D. Sharp, M. Ouyang, A. Konkimalla, R. N. Husson, N. A. Woychik, Mycobacterial toxin MazF-mt6 inhibits translation through cleavage of 23S rRNA at the ribosomal A site, Proceedings of the National Academy of Sciences, 2013, 110, 21, 8501

    CrossRef

  32. 32
    S. Sanyal, S. K. Banerjee, R. Banerjee, J. Mukhopadhyay, M. Kundu, Polyphosphate kinase 1, a central node in the stress response network of Mycobacterium tuberculosis, connects the two-component systems MprAB and SenX3-RegX3 and the extracytoplasmic function sigma factor, sigma E, Microbiology, 2013, 159, Pt_10, 2074

    CrossRef

  33. 33
    Christopher Dye, Philippe Glaziou, Katherine Floyd, Mario Raviglione, Prospects for Tuberculosis Elimination, Annual Review of Public Health, 2013, 34, 1, 271

    CrossRef

  34. 34
    Joanna Nowakowska, James D. Oliver, Resistance to environmental stresses by Vibrio vulnificus in the viable but nonculturable state, FEMS Microbiology Ecology, 2013, 84, 1
  35. 35
    Hyoun Sook Kim, Jieun Kim, Ha Na Im, Ji Young Yoon, Doo Ri An, Hye Jin Yoon, Jin Young Kim, Hye Kyeoung Min, Soon-Jong Kim, Jae Young Lee, Byung Woo Han, Se Won Suh, Structural basis for the inhibition of Mycobacterium tuberculosis L,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains, Acta Crystallographica Section D, 2013, 69, 3
  36. 36
    Dominic Böth, Eva Maria Steiner, Daniela Stadler, Ylva Lindqvist, Robert Schnell, Gunter Schneider, Structure of LdtMt2, an L,D-transpeptidase from Mycobacterium tuberculosis, Acta Crystallographica Section D, 2013, 69, 3
  37. 37
    Ömer Poyraz, Variam Ullas Jeankumar, Shalini Saxena, Robert Schnell, Martin Haraldsson, Perumal Yogeeswari, Dharmarajan Sriram, Gunter Schneider, Structure-Guided Design of Novel Thiazolidine Inhibitors ofO-Acetyl Serine Sulfhydrylase from Mycobacterium tuberculosis, Journal of Medicinal Chemistry, 2013, 56, 16, 6457

    CrossRef

  38. You have free access to this content38
    Charles C. Wang, Bingdong Zhu, Xionglin Fan, Brigitte Gicquel, Ying Zhang, Systems approach to tuberculosis vaccine development, Respirology, 2013, 18, 3
  39. 39
    Satria A. Prabowo, Matthias I. Gröschel, Ed D. L. Schmidt, Alena Skrahina, Traian Mihaescu, Serap Hastürk, Rotislav Mitrofanov, Edita Pimkina, Ildikó Visontai, Bouke de Jong, John L. Stanford, Père-Joan Cardona, Stefan H. E. Kaufmann, Tjip S. van der Werf, Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines, Medical Microbiology and Immunology, 2013, 202, 2, 95

    CrossRef

  40. 40
    Olga T. Schubert, Jeppe Mouritsen, Christina Ludwig, Hannes L. Röst, George Rosenberger, Patrick K. Arthur, Manfred Claassen, David S. Campbell, Zhi Sun, Terry Farrah, Martin Gengenbacher, Alessio Maiolica, Stefan H.E. Kaufmann, Robert L. Moritz, Ruedi Aebersold, The Mtb Proteome Library: A Resource of Assays to Quantify the Complete Proteome of Mycobacterium tuberculosis, Cell Host & Microbe, 2013, 13, 5, 602

    CrossRef

  41. 41
    Mette Hamborg, Ryan Kramer, Carole E. Schanté, Else Marie Agger, Dennis Christensen, Lene Jorgensen, Camilla Foged, C. Russell Middaugh, The Physical Stability of the Recombinant Tuberculosis Fusion Antigens H1 and H56, Journal of Pharmaceutical Sciences, 2013, 102, 10
  42. 42
    Stefan H.E. Kaufmann, Tuberculosis vaccines: Time to think about the next generation, Seminars in Immunology, 2013, 25, 2, 172

    CrossRef

  43. 43
    Brian D. Robertson, Danny Altmann, Clif Barry, Bill Bishai, Stewart Cole, Thomas Dick, Ken Duncan, Chris Dye, Sabine Ehrt, Hanif Esmail, JoAnne Flynn, Richard Hafner, Gray Handley, Willem Hanekom, Paul van Helden, Gilla Kaplan, Stefan H.E. Kaufmann, Peter Kim, Christian Lienhardt, Valerie Mizrahi, Eric Rubin, Dirk Schnappinger, David Sherman, Jelle Thole, Omar Vandal, Gerhard Walzl, Digby Warner, Robert Wilkinson, Douglas Young, Detection and treatment of subclinical tuberculosis, Tuberculosis, 2012, 92, 6, 447

    CrossRef

  44. 44
    Rajesh Jayachandran, Nicole Scherr, Jean Pieters, Elimination of intracellularly residingMycobacterium tuberculosisthrough targeting of host and bacterial signaling mechanisms, Expert Review of Anti-infective Therapy, 2012, 10, 9, 1007

    CrossRef

  45. 45
    A.M.G.A. Laheij, J.O. Kistler, G.N. Belibasakis, H. Välimaa, J.J. de Soet, Healthcare-associated viral and bacterial infections in dentistry, Journal of Oral Microbiology, 2012, 4, 0

    CrossRef

  46. 46
    Stefan HE Kaufmann, Martin Gengenbacher, Recombinant live vaccine candidates against tuberculosis, Current Opinion in Biotechnology, 2012, 23, 6, 900

    CrossRef

  47. 47
    Jansy Sarathy, Véronique Dartois, Edmund Lee, The Role of Transport Mechanisms in Mycobacterium Tuberculosis Drug Resistance and Tolerance, Pharmaceuticals, 2012, 5, 12, 1210

    CrossRef

  48. 48
    Stefan H.E. Kaufmann, Tuberculosis vaccine development: strength lies in tenacity, Trends in Immunology, 2012, 33, 7, 373

    CrossRef